DCALDishman Carbogen Amcis Ltd.
Dishman Carbogen Amcis Q2 FY27 Results: Consolidated Net Loss ₹66.73 Crore on Total Income of ₹511 Crore
- Earnings
- CDMO pharmaceuticals

Dishman Carbogen Amcis (NSE: DCAL) reported a consolidated total income of ₹510.93 crore and a net loss of ₹66.73 crore for the quarter ended 30 Sep 2026, it said in a filing on 13 Nov 2026. The standalone total income was ₹87.38 crore, with a net loss of ₹25.27 crore.
Key highlights
Consolidated
Including its subsidiaries
- Total income: ₹510.93 crore, down 22.7% YoY and 26.6% QoQ
- Net profit: Loss of ₹66.73 crore against a profit of ₹65.27 crore a year earlier
- EPS: Basic loss of ₹4.26 per share, against earnings of ₹4.16 a year earlier
- Finance costs: ₹40.10 crore, 7.8% of total income
Standalone
The company on its own, without its subsidiaries
- Total income: ₹87.38 crore, up 22.3% YoY and 15.0% QoQ
- Net profit: Loss of ₹25.27 crore against a loss of ₹13.60 crore a year earlier
- EPS: Basic loss of ₹1.61 per share, against a loss of ₹0.87 a year earlier
- Finance costs: ₹23.04 crore, 26.4% of total income
Summary
| Particulars | Q2 FY27 | Q2 FY26 | YoY | Q1 FY27 | QoQ |
|---|---|---|---|---|---|
| 510.93 | 660.76 | -22.7% | 695.80 | -26.6% | |
| Revenue from operations | 507.37 | 652.65 | -22.3% | 677.64 | -25.1% |
| Other income | 3.56 | 8.11 | -56.1% | 18.16 | -80.4% |
| -66.73 | 65.27 | n/a | -57.88 | -15.3% | |
| Profit before tax | -81.00 | 30.54 | n/a | -51.22 | -58.1% |
| Finance costs | 40.10 | 42.33 | -5.3% | 37.09 | +8.1% |
| Depreciation | 90.42 | 84.13 | +7.5% | 90.68 | -0.3% |
| Tax expense | -14.27 | -34.73 | +58.9% | 6.66 | n/a |
| Net profit margin | -13.06% | 9.88% | -22.94 pp | -8.32% | -4.74 pp |
| EPS, basic (₹) | -4.26 | 4.16 | n/a | -3.69 | -15.4% |
Figures are in ₹ crore; YoY compares with Q2 FY26 and QoQ with Q1 FY27. Click Total income or Net profit to see the rows behind them.
Consolidated total income fell 22.7% YoY to ₹510.93 crore, and the group moved from a profit of ₹65.27 crore to a loss of ₹66.73 crore. Revenue from operations fell 22.3% to ₹507.37 crore, while other income fell 56.1% to ₹3.56 crore. Other income is now 0.7% of total income, so the income line is mostly operating revenue.
Finance costs of ₹40.10 crore are 7.8% of total income, and depreciation of ₹90.42 crore rose 7.5% from a year earlier. Profit before tax was a loss of ₹81.00 crore, against a profit of ₹30.54 crore a year earlier, and tax was a credit of ₹14.27 crore.
The notes say that goodwill from the 2016-17 amalgamation is now amortised over a revised life of 99 years, and that without this treatment depreciation for the quarter would have been ₹1.66 crore lower. The notes also say that the exceptional item of ₹1.69 crore in the previous quarter, transaction costs for an abandoned QIP, was written off in the current quarter. The notes do not say why the quarter's profit fell into a loss.
The company says it opted for Section 200 of the Income Tax Act, 2025, from FY 2026-27 and that its effective tax rate has changed as a result. The filing does not give the effect of this in figures. Net profit for the half year is a loss of ₹124.61 crore, against a profit of ₹88.68 crore a year earlier.
| Particulars | Q2 FY27 | Q2 FY26 | YoY | Q1 FY27 | QoQ |
|---|---|---|---|---|---|
| 87.38 | 71.47 | +22.3% | 75.97 | +15.0% | |
| Revenue from operations | 83.59 | 60.30 | +38.6% | 57.08 | +46.4% |
| Other income | 3.79 | 11.17 | -66.1% | 18.89 | -79.9% |
| -25.27 | -13.60 | -85.8% | -23.91 | -5.7% | |
| Profit before tax | -33.76 | -20.82 | -62.2% | -31.70 | -6.5% |
| Finance costs | 23.04 | 20.61 | +11.8% | 21.71 | +6.1% |
| Depreciation | 15.00 | 15.79 | -5.0% | 15.37 | -2.4% |
| Tax expense | -8.49 | -7.22 | -17.6% | -7.79 | -9.0% |
| Net profit margin | -28.92% | -19.03% | -9.89 pp | -31.47% | +2.55 pp |
| EPS, basic (₹) | -1.61 | -0.87 | -85.1% | -1.52 | -5.9% |
Figures are in ₹ crore; YoY compares with Q2 FY26 and QoQ with Q1 FY27. Click Total income or Net profit to see the rows behind them.
Standalone net profit fell from a loss of ₹13.60 crore to a loss of ₹25.27 crore, so the loss widened even as income rose.
Standalone finance costs of ₹23.04 crore are 26.4% of total income, up 11.8% from a year earlier. Standalone profit before tax was a loss of ₹33.76 crore, and the tax line was a credit of ₹8.49 crore.
Consolidated net loss of ₹66.73 crore is ₹41.46 crore larger than the standalone loss of ₹25.27 crore.
Inference
The filing records ₹15.00 crore of secured debentures allotted on 28 Sep 2026 and ₹75.00 crore allotted on 17 Aug 2026, both on a private placement basis, with no deviation in use of proceeds. The company also reports paying a ₹49.99 crore debenture's principal and interest due 17 Jul 2026, and quarterly interest of ₹50.00 crore debentures due 26 Sep 2026 paid within the window. Net worth is ₹6,671.07 crore and the debt-equity ratio is 0.47 times as on 30 Sep 2026.
The filing does not say the reason for the fall in profit, the reason other income fell, or what funding the abandoned QIP was meant for, and it does not give the effect of the new tax section in figures.
Filed with BSE on . Reference: Original filing (PDF)
Disclaimer:
The information available on this article is provided for education and informational purposes only. It does not constitute or provide financial, investment or trading advice and should not be construed as an endorsement of any specific stock or financial strategy in any form or manner. We do not make any representations or warranties regarding the quality, reliability, or accuracy of the information provided. This website may contain links to third-party content. We are not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. We are not liable for any decisions made or actions taken based on the information provided on this website.

